Blonder Tongue Laboratories Overview
Blonder Tongue Laboratories (BDRL) has a ROE of 64.71%, above the Technology sector average of 57.49%.
Get informed when a big investor buys or sells
+ Follow64.71%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for BDRL is 64.71%. That is above the Technology sector average of 57.49%. Investors often review this figure alongside Blonder Tongue Laboratories's historical trend and sector peers before judging valuation or financial health.
Against Technology companies, BDRL currently prints 64.71% for ROE, while the sector average sits near 57.49%. That is roughly 12.6% above the sector mean. Large gaps often invite a closer look at Blonder Tongue Laboratories's growth, margins, and balance sheet.
Return on Equity shows how effectively Blonder Tongue Laboratories converts resources into returns. At 64.71%, BDRL may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BDRL's ROE (64.71%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Blonder Tongue Laboratories's ROE against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.
